OFDT Documentation

  • Recherche
    • Recherche simple
    • Périodiques
    • Publications OFDT
    • Textes législatifs
    • Nos dernières publications
  • Sélections
    • Usages de drogues à l’adolescence
    • Usages de drogues féminins
    • Drogues et sécurité routière
    • Addictions en milieu professionnel
    • Addictions en milieu carcéral
  • À propos
    • Présentation
    • Contact
Aide

Rechercher

Aide

Recherche avancée

Périodiques

Portail documentaire

  • A-
  • A
  • A+

Site OFDT

Historique

Accès réservé à l'OFDT et ses partenaires



Mot de passe oublié ?
  • Recherche
    • Recherche simple
    • Périodiques
    • Publications OFDT
    • Textes législatifs
    • Nos dernières publications
  • Sélections
    • Usages de drogues à l’adolescence
    • Usages de drogues féminins
    • Drogues et sécurité routière
    • Addictions en milieu professionnel
    • Addictions en milieu carcéral
  • À propos
    • Présentation
    • Contact

Rechercher

Aide

Recherche avancée

Périodiques

  1. Accueil
  2. Retour
Nouvelle recherche Votre compte

Auteur P. VICKERMAN

Documents disponibles écrits par cet auteur (44)

  Tris disponibles Ajouter le résultat à votre sélection
  Affiner la recherche
Nouveauté
Acceptability of low dead space syringes and implications for their introduction: A qualitative study in the West of England

Acceptability of low dead space syringes and implications for their introduction: A qualitative study in the West of England

J. M. KESTEN ; R. AYRES ; J. NEALE ; J. CLARK ; P. VICKERMAN ; M. HICKMAN ; S. REDWOOD | 2017
Dans International Journal of Drug Policy (Vol.39, January 2017) Article : Périodique
Background: It is recommended that needle and syringe programmes (NSP) distribute low dead space syringes (LDSS) to reduce blood-borne virus transmission. We explored the acceptability of detachable LDSS among people who inject drugs (PWID) and [...]
Plus d'info
Ajouter à la sélection Ajouter à la sélection
Associations between national development indicators and the age profile of people who inject drugs: results from a global systematic review and meta-analysis

Associations between national development indicators and the age profile of people who inject drugs: results from a global systematic review and meta-analysis

L. A. HINES ; A. TRICKEY ; J. LEUNG ; S. LARNEY ; A. PEACOCK ; L. DEGENHARDT ; S. COLLEDGE ; M. HICKMAN ; J. GREBELY ; E. B. CUNNINGHAM ; J. STONE ; K. DUMCHEV ; P. GRIFFITHS ; P. VICKERMAN ; R. P. MATTICK ; M. LYNSKEY | 2020
Dans Lancet Global Health (The) (Vol.8, n°1, January 2020) Article : Périodique
BACKGROUND: Globally, an estimated 15.6 million people inject drugs. We aimed to investigate global variation in the age profile of people who inject drugs (PWID), identify country-level factors associated with age of PWID, and assess the associ[...]
Plus d'info
Ajouter à la sélection Ajouter à la sélection
open_link_url_notice Lien externe
Can needle and syringe programmes and opiate substitution therapy achieve substantial reductions in hepatitis C virus prevalence? Model projections for different epidemic settings

Can needle and syringe programmes and opiate substitution therapy achieve substantial reductions in hepatitis C virus prevalence? Model projections for different epidemic settings

P. VICKERMAN ; N. MARTIN ; K. TURNER ; M. HICKMAN | 2012
Dans Addiction (Vol.107, n°11, November 2012) Article : Périodique
Aims: To investigate the impact of scaling-up opiate substitution therapy (OST) and high coverage needle and syringe programmes (100%NSP - obtaining more sterile syringes than you inject) on HCV prevalence among injecting drug users (IDUs). De[...]
Plus d'info
Ajouter à la sélection Ajouter à la sélection
open_link_url_notice Lien externe
Combination interventions to prevent HCV transmission among people who inject drugs: modeling the impact of antiviral treatment, needle and syringe programs, and opiate substitution therapy

Combination interventions to prevent HCV transmission among people who inject drugs: modeling the impact of antiviral treatment, needle and syringe programs, and opiate substitution therapy

N. K. MARTIN ; M. HICKMAN ; S. J. HUTCHINSON ; D. J. GOLDBERG ; P. VICKERMAN | 2013
Dans Clinical Infectious Diseases (Vol.57, Suppl.2, August 2013) Article : Périodique
BACKGROUND: Interventions such as opiate substitution therapy (OST) and high-coverage needle and syringe programs (HCNSP) cannot substantially reduce hepatitis C virus (HCV) prevalence among people who inject drugs (PWID). HCV antiviral treatmen[...]
Plus d'info
Ajouter à la sélection Ajouter à la sélection
open_link_url_notice Lien externe
Could low dead-space syringes really reduce HIV transmission to low levels? [Commentary]

Could low dead-space syringes really reduce HIV transmission to low levels? [Commentary]

P. VICKERMAN ; N. K. MARTIN ; M. HICKMAN | 2013
Dans International Journal of Drug Policy (Vol.24, n°1, January 2013) Article : Périodique
Studies published by Zule and colleagues have suggested that use of low dead-space syringes (LDSS) instead of high dead-space syringes (HDSS) by injecting drug users (IDUs) could dramatically reduce HIV transmission. However, evidence is limited[...]
Plus d'info
Ajouter à la sélection Ajouter à la sélection
open_link_url_notice Lien externe
Detachable low dead space syringes for the prevention of hepatitis C among people who inject drugs in Bristol, UK: an economic evaluation

Detachable low dead space syringes for the prevention of hepatitis C among people who inject drugs in Bristol, UK: an economic evaluation

E. HANCOCK ; Z. WARD ; R. AYRES ; J. NEALE ; D. HUSSEY ; J. M. KESTEN ; M. HICKMAN ; P. VICKERMAN | 2020
Dans Addiction (Vol.115, n°4, April 2020) Article : Périodique
BACKGROUND AND AIMS: Traditional detachable syringes used by people who inject drugs (PWID) retain larger volumes of blood when the plunger is depressed than syringes with fixed needles-referred to as high (HDSS) and low dead space syringes (LDS[...]
Plus d'info
Ajouter à la sélection Ajouter à la sélection
open_link_url_notice Lien externe
Effectiveness of needle/syringe programmes and opiate substitution therapy in preventing HCV transmission among people who inject drugs [Protocol]

Effectiveness of needle/syringe programmes and opiate substitution therapy in preventing HCV transmission among people who inject drugs [Protocol]

L. PLATT ; J. REED ; S. MINOZZI ; P. VICKERMAN ; H. HAGAN ; C. FRENCH ; A. JORDAN ; L. DEGENHARDT ; V. HOPE ; S. HUTCHINSON ; L. MAHER ; N. PALMATEER ; A. TAYLOR ; M. HICKMAN | 2016
Dans Cochrane Database of Systematic Reviews (n°1, 2016) Article : Périodique
This is the protocol for a review and there is no abstract. The objectives are as follows: 1. To assess the impact of needle/syringe programmes with and without opiate substitution therapy (OST) on the incidence of HCV infection among people w[...]
Plus d'info
Ajouter à la sélection Ajouter à la sélection
open_link_url_notice Lien externe
Epidemiology of injecting drug use, prevalence of injecting-related harm, and exposure to behavioural and environmental risks among people who inject drugs: a systematic review

Epidemiology of injecting drug use, prevalence of injecting-related harm, and exposure to behavioural and environmental risks among people who inject drugs: a systematic review

L. DEGENHARDT ; P. WEBB ; S. COLLEDGE-FRISBY ; J. IRELAND ; A. WHEELER ; S. OTTAVIANO ; A. WILLING ; A. KAIROUZ ; E. B. CUNNINGHAM ; B. HAJARIZADEH ; J. LEUNG ; L. T. TRAN ; O. PRICE ; A. PEACOCK ; P. VICKERMAN ; M. FARRELL ; G. J. DORE ; M. HICKMAN ; J. GREBELY | 2023
Dans Lancet Global Health (The) (Vol.11, n°5, May 2023) Article : Périodique
BACKGROUND: People who inject drugs are exposed to various and changing risk environments and are at risk of multiple harms related to injecting drug use (IDU). We aimed to undertake a global systematic review of the prevalence of IDU, key IDU-r[...]
Plus d'info
Ajouter à la sélection Ajouter à la sélection
open_link_url_notice Lien externe
Evaluating the cost-effectiveness of existing needle and syringe programmes in preventing hepatitis C transmission in people who inject drugs

Evaluating the cost-effectiveness of existing needle and syringe programmes in preventing hepatitis C transmission in people who inject drugs

S. SWEENEY ; Z. WARD ; L. PLATT ; L. GUINNESS ; M. HICKMAN ; V. HOPE ; L. MAHER ; J. IVERSEN ; S. J. HUTCHINSON ; J. SMITH ; R. AYRES ; I. HAINEY ; P. VICKERMAN | 2019
Dans Addiction (Vol.114, n°3, March 2019) Article : Périodique
AIM: To evaluate the cost-effectiveness of needle and syringe programmes (NSPs) compared with no NSPs on hepatitis C virus (HCV) transmission in the United Kingdom. DESIGN: Cost-effectiveness analysis from a National Health Service (NHS)/healt[...]
Plus d'info
Ajouter à la sélection Ajouter à la sélection
Frequency, factors and costs associated with injection site infections: findings from a national multi-site survey of injecting drug users in England

Frequency, factors and costs associated with injection site infections: findings from a national multi-site survey of injecting drug users in England

V. HOPE ; J. KIMBER ; P. VICKERMAN ; M. HICKMAN ; F. NCUBE | 2008
Dans BMC Infectious Diseases (Vol.8, n°120, 18 September 2008) Article : Périodique
BACKGROUND: Injection site infections among injecting drug users (IDUs) have been associated with serious morbidity and health service costs in North America. This study explores the frequency, factors and costs associated with injection site in[...]
Plus d'info
Ajouter à la sélection Ajouter à la sélection
open_link_url_notice Lien externe
Frequency of injecting among people who inject drugs: A systematic review and meta-analysis

Frequency of injecting among people who inject drugs: A systematic review and meta-analysis

S. COLLEDGE ; J. LEUNG ; S. LARNEY ; A. PEACOCK ; J. GREBELY ; M. HICKMAN ; E. CUNNINGHAM ; A. TRICKEY ; J. STONE ; P. VICKERMAN ; L. DEGENHARDT | 2020
Dans International Journal of Drug Policy (Vol.76, February 2020) Article : Périodique
BACKGROUND: People who inject drugs (PWID) do so at varying frequencies. More frequent injecting is associated with skin and soft tissue infection, blood borne viruses, and overdose. The aims of this review are to estimate the prevalence of inje[...]
Plus d'info
Ajouter à la sélection Ajouter à la sélection
Global coverage of interventions to prevent and manage drug-related harms among people who inject drugs: a systematic review

Global coverage of interventions to prevent and manage drug-related harms among people who inject drugs: a systematic review

S. COLLEDGE-FRISBY ; S. OTTAVIANO ; P. WEBB ; J. GREBELY ; A. WHEELER ; E. B. CUNNINGHAM ; B. HAJARIZADEH ; J. LEUNG ; A. PEACOCK ; P. VICKERMAN ; M. FARRELL ; G. J. DORE ; M. HICKMAN ; L. DEGENHARDT | 2023
Dans Lancet Global Health (The) (Vol.11, n°5, May 2023) Article : Périodique
BACKGROUND: Harm reduction and treatment programmes are essential for reducing harms for people who inject drugs (PWID). We aimed to update estimates from a 2017 review of global coverage of needle and syringe exchange programmes (NSPs), opioid [...]
Plus d'info
Ajouter à la sélection Ajouter à la sélection
open_link_url_notice Lien externe
A global meta-analysis of the prevalence of HIV, hepatitis C virus, and hepatitis B virus among people who inject drugs - Do gender-based differences vary by country-level indicators?

A global meta-analysis of the prevalence of HIV, hepatitis C virus, and hepatitis B virus among people who inject drugs - Do gender-based differences vary by country-level indicators?

J. LEUNG ; A. PEACOCK ; S. COLLEDGE ; J. GREBELY ; E. B. CUNNINGHAM ; M. HICKMAN ; P. VICKERMAN ; J. STONE ; A. TRICKEY ; K. DUMCHEV ; M. LYNSKEY ; L. HINES ; P. GRIFFITHS ; R. P. MATTICK ; L. DEGENHARDT ; S. LARNEY | 2019
Dans Journal of Infectious Diseases (Vol.220, n°1, July 2019) Article : Périodique
BACKGROUND: Women-specific factors exist that increases vulnerability to drug-related harms from injection drug use, including blood-borne viruses (BBVs), but gender-based differences in BBV prevalence have not been systematically examined. MET[...]
Plus d'info
Ajouter à la sélection Ajouter à la sélection
Global patterns of opioid use and dependence: harms to populations, interventions, and future action [Drug use 1]

Global patterns of opioid use and dependence: harms to populations, interventions, and future action [Drug use 1]

L. DEGENHARDT ; J. GREBELY ; J. STONE ; M. HICKMAN ; P. VICKERMAN ; B. D. L. MARSHALL ; J. BRUNEAU ; F. L. ALTICE ; G. HENDERSON ; A. RAHIMI-MOVAGHAR ; S. LARNEY | 2019
Dans Lancet (The) (Vol.394, n°10208, 26 October 2019) Article : Périodique
We summarise the evidence for medicinal uses of opioids, harms related to the extramedical use of, and dependence on, these drugs, and a wide range of interventions used to address these harms. The Global Burden of Diseases, Injuries, and Risk F[...]
Plus d'info
Ajouter à la sélection Ajouter à la sélection
Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review

Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review

L. DEGENHARDT ; A. PEACOCK ; S. COLLEDGE ; J. LEUNG ; J. GREBELY ; P. VICKERMAN ; J. STONE ; E. B. CUNNINGHAM ; A. TRICKEY ; K. DUMCHEV ; M. LYNSKEY ; P. GRIFFITHS ; R. P. MATTICK ; M. HICKMAN ; S. LARNEY | 2017
Dans Lancet Global Health (The) (Vol.5, n°12, December 2017) Article : Périodique
Background: Sharing of equipment used for injecting drug use (IDU) is a substantial cause of disease burden and a contributor to blood-borne virus transmission. We did a global multistage systematic review to identify the prevalence of IDU among[...]
Plus d'info
Ajouter à la sélection Ajouter à la sélection
open_link_url_notice Lien externe

première page page précédente 1 2 3 page suivante dernière page (1 - 15 / 44) Par page : 25 50 100 200

Contact

OFDT

69 rue de Varenne
75700 PARIS

Tel : (+33) 01 41 62 77 16

Accès rapides

  • L’établissement
  • Les partenaires
  • La lettre d’information

Avertissement

Toute inclusion dans la base documentaire ne vaut pas crédit scientifique de l'OFDT

Contact

OFDT

69 rue de Varenne
75700 PARIS

Tel : (+33) 01 41 62 77 16

Accès rapides

  • L’établissement
  • Les partenaires
  • La lettre d’information

Avertissement

Toute inclusion dans la base documentaire ne vaut pas crédit scientifique de l'OFDT

Suivez-nous

  • Traitement des données personnelles
  • Mentions légales
  • Plan du site